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Pituitary tumour apoplexy with visual ﬁeld
defects in pregnancy managed with bromo-
criptine, hydrocortisone and thyroxine
Case report
Neuritis retrobulbaris was diagnosed in a 27-year-
old nulligravid woman with an uneventful
medical history. The condition spontaneously
resolved within 2 months. Magnetic resonance
imaging (MRI) was performed and by coincidence
a pituitary tumour was found without suprasellar
expansion or compression of the optic chiasma of
10 mm. The patient wanted to become pregnant
and discontinued oral contraceptive use 2
months earlier. There was no galactorrhoea. Endo-
crinological analysis revealed a hyperprolactine-
mia of 3138 μMol/l. The diagnosis of a
microprolactinoma with subsequent hyperprolac-
tinemia suspected of causing secondary
amenorrhoea was made. Bromocriptine 2.5 mg
medication was started twice daily. Soon there-
after the patient became pregnant and the bromo-
criptine medication was ceased. At 10 weeks’ of
gestation she presented with a continuous head-
ache and visual complaints of the left eye. Endo-
crinological tests demonstrated an increased
prolactinconcentrationof5660 μMol/landadisrup-
tion of the pituitary-thyroid axis and the
pituitary-adrenalaxis(Table1).Visualﬁeldexamin-
ation disclosed defects compatible with com-
pression of the optic chiasm and MRI
demonstrated tumour growth of the prolactinoma,
suprasellarextensionand a marked compression of
the optic chiasm. Liquefaction was seen within the
prolactinoma, indicating an apoplexy within the
tumour,atthismomentdiagnosedasamacroprolac-
tinoma.(Figure 1A)
Both neurosurgical treatment and medication
was considered, and the latter was chosen
because of the patients’ pregnancy. Medication
consisted of bromocriptine 2.5 mg twice daily,
levothyroxine 150 μg once a day and hydrocorti-
sone three times a day in the following dose
scheme: 15 mg-7.5 mg-7.5 mg. At 19 weeks of
pregnancy, the headache disappeared, prolactin
levels decreased and visual ﬁeld defects
improved. At 33 weeks of pregnancy, laboratory
values and visual ﬁeld examination were returned
to normal. (Table 1) Medication was continued
and the further course of pregnancy was unevent-
ful. The patient was delivered vaginally of a
healthy daughter of 3300 g at 40 weeks’ of ges-
tation. The mother had no wish to take up breast-
feeding. Six weeks after delivery there were no
physical complaints and no visual ﬁeld deﬁcits.
MRI showed a major decline of the adenoma.
(Figure 1B) Thyroxine could be discontinued at
that time, hydrocortisone and bromocriptine
were continued.
Discussion
Lactotrophic cells of the anterior pituitary gland
are covered with oestrogen receptors mediating
hyperplasia of these lactotrophic cells and thus
a physiological increase of the prolactin produ-
cing part of the pituitary gland during preg-
nancy.
1 The combination of a pituitary adenoma
and this physiological increase may compromise
the blood supply, either leading to infarction or
haemorrhage.
2 Pituitary tumour apoplexy refers
to a clinical syndrome consisting of a constella-
tion of signs and symptoms that occur with
rapid expansion of the contents of the sella
turcica. The occurrence during pregnancy is rare
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CASE REPORT
1and there have been twelve case reports of pitu-
itary apoplexy during pregnancy, of which only
six evolved from prolactinomas (Table 2). The ear-
liest symptoms of a pituitary apoplexy are
sudden and severe, retro-orbital, bifrontal or sub-
occipital headache, which may be accompanied
by nausea and vomiting.
2 The increase in intra-
sellar pressure can lead to compression and
necrosis of pituitary tissue resulting in hypopitui-
tarism. The increased pressure can also endanger
cranial nerves in cavernous sinus (cranial nerves
III, IV, V, and VI). Clinically, such an extension
is seen in 70% of patients, which can cause diplo-
pia and other manifestations of cranial nerve
palsies.
3
MRI and endocrinological evaluation are
essential diagnostic tools for diagnosis and
follow-up. Initial management in acute pituitary
apoplexy consists of replacement of the deﬁcient
hormones, especially corticosteroid to treat
adrenal insufﬁciency and the effects of edema on
suprasellar structures.
2,3 Following stabilization
there is no consensus regarding the treatment of
pituitary apoplexy in pregnant patients: trans-
sphenoidal resection or medical treatment with
dopamine agonists and corticosteroids. The
latter is the ﬁrst choice of treatment in patients
without visual ﬁeld defects and in patients with
a rapid improvement of visual ﬁeld defects.
3
Transphenoidal resection was performed in
those cases presenting with major symptoms
(Table 2). Corticosteroids should be maintained
as replacement therapy. No teratogenic side
effects have been reported of bromocriptine
administration during conception and preg-
nancy.
3 This case report indicates that even in
patients with a major pituitary apoplexy and
visual ﬁeld defects in pregnancy, conservative
medical treatment should be the ﬁrst choice of
treatment.
Figure 1
MRI T1 showing liquefaction within the pituitary tumour
(a) MRI taken at a gestational age of 10 week. Pituitary tumour of
19,5 mm, evidence of a liquid level, suitable with an apoplexy
within the prolactinoma. Strong compression of the optic chiasm
with cranial movement.
(b) MRI taken 5 weeks postpartum. Pituitary tumour of less than
10 mm, little impression of the sphenoidal sinus. Pituitary stalk is
removed to the left.
Table 1
Summary of endocrine biochemical results
References Before
therapy
At the time
of conception
10
weeks
19
weeks
33
weeks
37
weeks
5 weeks post
partum
TSH 0.4–4.2 mU/l 3.6 2.8 0.93 0.85 0.059 0.028 0.021
FT-4 11–21 pmol/l 14 16 11 9 12.9 14.5 16.7
Prolactin 60–500 mU/l 3138 95 5660 509 331 273 77
Cortisol 0.18–0.72 μMol/L 0.45 – – 0.22 0.78 1.02 0.36
ACTH 7–50 ng/l1 8 – – 1 5 – – <5.0
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Table 2
Treatment and outcome of pituitary apoplexy with underlying prolactinoma in pregnancy
Author/
Reference
Presentation Treatment Outcome
Lamberts et al.
1979
4
Headache, left abduces
nerve paresis, vomiting
Hydrocortison,
thyroxine
Complete recovery
O’Donovan
et al. 1986
5
Headache, left sided
ptosis, coma
Left frontotemporal
craniotomy,
bromocriptine
3rd left cranial nerve palsy with
dilated pupil, slight ptosis and
absent upper gaze
Gondim et al.
2003
6
Headache, unilateral
visual loss, left sided
opthalmoplegia
Transsphenoidal
decompression
Complete recovery
De Heide et al.
2004
2
Headache, vomiting,
Hyponatremia shock
Hydrocortisone,
thyroxine,
desmopressin
Panhypopituitarism
Okafor et al.
2009
7
Headache, decreased
visual aquity, vomiting
Bromocriptine Death due to cardiac arrest post
partum
Ginath et al.
2010
8
Headache, nausea Bromocriptine after
cesarean section
Complete recovery
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